Key facts
- Evaro’s last known valuation is $86.9M (Jan 2026).
- It has raised $28.7M; the latest was Accelerator/Incubator in Mar 2026.
- Notable investors include Tech Nation Group, SyndicateRoom, British International Investment, AlbionVC, Life Extension Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Evaro
- ·The full record, as it builds
Funding rounds
No funding rounds for Evaro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evaro
Operator of an online health hub platform intended to offer patients paperless prescriptions and delivery. The company's platform helps its users choose medication by answering a questionnaire and delivering prescription treatment based on a prescribing system that reduces the need for excess paper waste, enabling healthcare professionals to help patients access healthcare online for confidential advice easily.
- Sector
- Healthcare
- HQ
- Norwich, United Kingdom
- Founded
- 2017
- Employees
- 79
- Website
- evaro.com/
- Ownership
- Privately Held (backing)
Evaro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evaro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evaro in its N-PORT filings yet. We sweep new filings monthly.